Related Experiment Video
Updated: Mar 21, 2026

In Vivo Quantitative Assessment of Myocardial Structure, Function, Perfusion and Viability Using Cardiac Micro-computed Tomography
Published on: February 16, 2016
Ventricular longitudinal function is associated with microvascular obstruction and intramyocardial haemorrhage
Pankaj Garg1, Ananth Kidambi1, James R J Foley1
1Multidisciplinary Cardiovascular Research Centre & Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds , UK.
Mitral annular plane systolic excursion (MAPSE) can predict microvascular obstruction and intramyocardial hemorrhage after ST-elevation myocardial infarction. This assessment of longitudinal function offers valuable prognostic information post-reperfusion.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Myocardial Infarction Research
Background:
- Microvascular obstruction (MVO) and intramyocardial hemorrhage (IMH) are independent predictors of adverse prognosis in reperfused ST-elevation myocardial infarction (STEMI).
- Mitral annular plane systolic excursion (MAPSE) is a key echocardiographic measure of left ventricular (LV) longitudinal function.
Purpose of the Study:
- To evaluate the association between acute MAPSE, assessed via cardiovascular magnetic resonance (CMR), and the presence of MVO and IMH.
- To determine if acute MAPSE can predict subsequent left ventricular (LV) remodeling after STEMI.
Main Methods:
- Cardiovascular magnetic resonance (CMR) imaging including cine, T2-weighted, T2*, and late gadolinium enhancement (LGE) was performed within 3 days of reperfused STEMI in 54 patients.
- Infarct size, MVO, and IMH were quantified using LGE and T2-weighted/T2* imaging.
- Averaged-MAPSE was calculated from four-chamber cine views.
Main Results:
- MVO and IMH were present in 59% and 57% of patients, respectively.
- The presence of MVO and IMH was significantly associated with lower averaged-MAPSE (p<0.001 for both).
- MAPSE demonstrated high sensitivity and specificity for detecting MVO and IMH, with MAPSE ≤10.6 mm being a significant threshold.
Conclusions:
- Acute MAPSE, assessed by CMR, serves as an independent predictor of MVO and IMH in patients with STEMI.
- MAPSE is a valuable tool for assessing myocardial injury and predicting adverse outcomes post-reperfusion therapy.
Related Concept Videos
Mitral Stenosis I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure II: Pathophysiology
Mitral Regurgitation I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy

